CONTACT
SITEMAP
HOME
COMPANY
Management
Board of Directors
Scientific Advisory Board
PRODUCTS
Pipeline
Clinical Trials
XmAb
®
Antibody Therapeutics
XmAb
®
2513
XmAb
®
5574 (MOR208)
XmAb
®
5592
XmAb
®
5871
XmAb
®
7195
XmAb
®
Candidate Discovery
XPro
®
Protein Therapeutics
XPro
®
1595
Dominant Negative Inhibitors
The TNF Superfamily
TECHNOLOGY
Achievements of PDA
®
Technology
XmAb
®
Technology
XmAb
®
Fc Technology
XmAb
®
Fv Technology
XPro
®
Technology
Advantages of XPro
®
Technology
ImmunoPDA
®
Technology
Patents
PARTNERING
Alliances
INVESTOR RESOURCES
Xencor Presentations
NEWS
Press Releases
Publications
Articles
Events
Event Archives
NEWS
Press Releases
Publications
Articles
Events
Event Archives
NEWS
JR Desjarlais and GA Lazar (2011)
Posted on
August 5, 2011
by
xencor
Modulation of antibody effector function. Experimental Cell Research 317(9)1278-1285